Request Deal Involvement

A group of investors led a $220m Series B round in Arsenal Biosciences.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Gwen Gordon Public Relations

pr advisors

Gwen Gordon Public Relations

Cooley

legal advisors

Cooley

or

Principals

SAN FRANCISCO FOUNDATION INVESTMENT COMPANY

bidder

SAN FRANCISCO FOUNDATION INVESTMENT COMPANY

THE UNIVERSITY OF CALIFORNIA

bidder

THE UNIVERSITY OF CALIFORNIA

SOFTBANK VISION FUND 2

bidder

SOFTBANK VISION FUND 2

GREEN SANDS EQUITY

bidder

GREEN SANDS EQUITY

EUCLIDEAN CAPITAL

bidder

EUCLIDEAN CAPITAL

BYERS CAPITAL

bidder

BYERS CAPITAL

EMERSON COLLECTIVE LLC

bidder

EMERSON COLLECTIVE LLC

ARSENAL BIOSCIENCES

target

ARSENAL BIOSCIENCES

BRISTOL MYERS SQUIBB COMPANY

bidder

BRISTOL MYERS SQUIBB COMPANY

KLEINER PERKINS

bidder

KLEINER PERKINS

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY

bidder

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY

WESTLAKE VILLAGE BIOPARTNERS

bidder

WESTLAKE VILLAGE BIOPARTNERS

SIXTH STREET PARTNERS

bidder

SIXTH STREET PARTNERS

WAYCROSS VENTURES

bidder

WAYCROSS VENTURES

HITACHI VENTURES

bidder

HITACHI VENTURES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - A group of investors led a $220m Series B round in Arsenal Biosciences.